CCA, a cassane diterpene from Caesalpinia bonduc ameliorates cognition impairment in Alzheimer’s disease mice by regulating neuroinflammation and autophagy

i

This article has been updated. A Correction to this article was published on .

i

The Original Article was published on

i

The Original Article was published on

i

This article has been updated

i

This article was retracted on

i

This article has been updated

Abstract

Alzheimer’s disease (AD) is a severe neurodegenerative disorder, with persistent neuroinflammation and impaired autophagy recognized as key contributing factors. CCA is a naturally occurring cassane diterpene compound derived from the seed of Caesalpinia bonduc. Our research is the first to explore the role and mechanism of CCA in treating Alzheimer’s disease. We assessed the levels of pro-inflammatory cytokines and autophagy in BV2 cells following lipopolysaccharide (LPS) treatment and anti-neuroinflammatory effects of CCA were evaluated in LPS-induced mice, with the underlying mechanisms explored using transcriptomic. Additionally, we examined the cognitive-enhancing effects of CCA in APP/PS1 mice and investigatedCaesalpinia bonduc associated molecular mechanisms through proteomic analysis, immunohistochemistry (IHC) and immunofluorescence (IF) assays. Finally, the molecular target of CCA was validated using molecular dynamics simulations and cellular thermal shift assay (CETSA). CCA can down-regulate the mRNA levels of inflammatory factors in BV2 cells stimulated by LPS, and has good permeability of blood-brain barrier. Furthermore, CCA ameliorated cognitive impairment and neuronal damage in both LPS-induced and APP/PS1 mice. And demonstrated that CCA mitigates neuroinflammation by driving microglial polarization from M1 to M2, a process potentially mediated by the AMPK/NF-κB pathway, thereby reducing tau pathology. Proteomic profiling and IHC revealed that CCA upregulates FOXG1 expression in APP/PS1 mice. Furthermore, the scTenifoldKnk confirmed that AMPK has a significant impact on the regulation of autophagy and inflammation response. Our findings verified that CCA exhibits anti-neuroinflammatory activity by AMPK/NF-κB pathway and activates autophagy via the AMPK-mTOR-FOXG1 signaling axis, which underscores its potential as a novel therapeutic option for the treatment of AD.

Keywords

Alzheimer’s disease / Neuroinflammation / Autophagy / scTenifoldKnk

CHANGE HISTORY

A Correction to this paper has been published:
https://doi.org

The Retraction Note was updated to reflect reception of statements of disagreement from all authors.

This article has been retracted.Please see the Retraction Notice for more detail:
https://doi.org

References

[1] Scheltens P, De Strooper B, Kivipelto M, et al. Alzheimer’s disease. Lancet. 2021; 397(10284):1577-1590. https://doi.org/10.1016/S0140-6736(20)32205-4.

[2] Bostancıklıoğlu M. An update on the interactions between Alzheimer’s disease, autophagy and inflammation. Gene . 2019; 705:157-166. https://doi.org/10.1016/j.gene.2019.04.040.

[3] Gu YY, Liu MX, Zhao XR, et al. Cordycepin promotes autophagic degradation of α-synuclein via CacyBP/SIP activation for ameliorating olfactory dysfunction against Parkinson’s disease. Free Radic Biol Med. 2025; 238:522-541. https://doi.org/10.1016/j.freeradbiomed.2025.07.010.

[4] Zhang XL, Gu YY, Liu YC, et al. Near-infrared enhanced organic Se-doped carbon nitride quantum dots nanozymes as SOD/CAT mimics for anti-Parkinson via ROS-NF-κB-NLRP3 inflammasome axis. Chem Eng J. 2024; 499:156028. https://doi.org/10.1016/j.cej.2024.156028.

[5] Zhang Z, Yang X, Song YQ, et al. Autophagy in Alzheimer’s disease pathogenesis: therapeutic potential and future perspectives. Ageing Res Rev. 2021; 72:101464. https://doi.org/10.1016/j.arr.2021.101464.

[6] Terao I, Kodama W . Comparative efficacy, tolerability and acceptability of donanemab, lecanemab, aducanumab and lithium on cognitive function in mild cognitive impairment and Alzheimer’s disease: a systematic review and network meta-analysis. Ageing Res Rev. 2024; 94:102203. https://doi.org/10.1016/j.arr.2024.102203.

[7] Colonna M, Butovsky O . Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol. 2017; 35:441-468. https://doi.org/10.1146/annurev-immunol-051116-052358.

[8] Hickman SE, Allison EK, El Khoury J . Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer’s disease mice. J Neurosci. 2008; 28(33):8354-8360. https://doi.org/10.1523/JNEUROSCI.0616-08.2008.

[9] Feng W, Zhang Y, Wang Z, et al. Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer’s disease mouse model with suppression of glymphatic clearance. Alzheimers Res Ther. 2020; 12(1):125. https://doi.org/10.1186/s13195-020-00688-1.

[10] Michelucci A, Heurtaux T, Grandbarbe L, et al. Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: effects of oligomeric and fibrillar amyloid-beta. J Neuroimmunol. 2009; 210(1-2):3-12. https://doi.org/10.1016/j.jneuroim.2009.02.003.

[11] Li Z, Zhang Z, Yu B . Unlocking the therapeutic potential of natural products for Alzheimer’s disease. J Med Chem. 2025; 68(3):2377-2402. https://doi.org/10.1021/acs.jmedchem.4c03049.

[12] Wang Y, Gao J, Yu Y, et al. A plant-derived glucocorticoid receptor modulator with potency to attenuate the side effects of glucocorticoid therapy. Br J Pharmacol. 2023; 180(2):194-213. https://doi.org/10.1111/bph.15957.

[13] Liu T, Li X, Ning Z, et al. Two new cassane-type diterpenoids from the seed kernels of Caesalpinia bonduc (Linn.) Roxb. and their anti-inflammatory activity. Nat Prod Res. 2022; 36(15):3901-3908. https://doi.org/10.1080/14786419.2021.1896511.

[14] Wang M, Yu S, Qi S, et al. Anti-inflammatory cassane-type diterpenoids from the seed kernels of Caesalpinia sinensis . J Nat Prod. 2021; 84(8):2175-2188. https://doi.org/10.1021/acs.jnatprod.1c00233.

[15] Liu T, Wang M, Qi S, et al. New cassane-type diterpenoids from kernels of Caesalpinia bonduc (Linn.) Roxb. and their inhibitory activities on phosphodiesterase (PDE) and nuclear factor-kappa B (NF-κB) expression. Bioorg Chem. 2020; 96:103573. https://doi.org/10.1016/j.bioorg.2020.103573.

[16] Liu W, Liu X, Tian L, et al. Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer’s disease. Eur J Med Chem. 2021; 222:113554. https://doi.org/10.1016/j.ejmech.2021.113554.

[17] Jiang X, Lu H, Li J, et al. A natural BACE1 and GSK3β dual inhibitor Notopterol effectively ameliorates the cognitive deficits in APP/PS1 Alzheimer’s mice by attenuating amyloid-β and tau pathology. Clin Transl Med. 2020; 10(3):e50. https://doi.org/10.1002/ctm2.50.

[18] Wang X, Zhang J, Wang S, et al. Berberine modulates gut microbiota to attenuate cerebral ferroptosis induced by ischemia-reperfusion in mice. Eur J Pharmacol. 2023; 953:175782. https://doi.org/10.1016/j.ejphar.2023.175782.

[19] Wiśniewski JR, Zougman A, Nagaraj N, et al. Universal sample preparation method for proteome analysis. Nat Methods. 2009; 6(5):359-362. https://doi.org/10.1038/nmeth.1326.

[20] Liao X, Xie Q, Liang M, et al. Glucosidase alpha neutral C promotes influenza virus replication by inhibiting proteosome-dependent degradation of hemagglutinin. Signal Transduct Target Ther. 2025; 10:131. https://doi.org/10.1038/s41392-025-02227-6.

[21] Li X, Li Y, Xiao J, et al. Unique DUOX2⁺ ACE2⁺ small cholangiocytes are pathogenic targets for primary biliary cholangitis. Nat Commun. 2023; 14(1):29. https://doi.org/10.1038/s41467-022-34606-w.

[22] Sherman BT, Hao M, Qiu J, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022; 50(W1):W216-W221. https://doi.org/10.1093/nar/gkac194.

[23] Huang DW, Sherman BT, Lempicki RA . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. https://doi.org/10.1038/nprot.2008.211.

[24] Mauersberger C, Schunkert H, Sager HB . Inflammation-related risk loci in genome-wide association studies of coronary artery disease. Cells. 2021; 10(2):440. https://doi.org/10.3390/cells10020440.

[25] Chen W, Yao S, Wan J, et al. BBB-crossing adeno-associated virus vector: an excellent gene delivery tool for CNS disease treatment. J Control Release. 2021; 333:129-138. https://doi.org/10.1016/j.jconrel.2021.03.029.

[26] Hansen DV, Hanson JE, Sheng M . Microglia in Alzheimer’s disease. J Cell Biol. 2018; 217(2):459-472. https://doi.org/10.1083/jcb.201709069.

[27] Wang D, Zhang X, Wang M, et al. Early activation of astrocytes does not affect amyloid plaque load in an animal model of Alzheimer’s disease. Neurosci Bull. 2018; 34(6):912-920. https://doi.org/10.1007/s12264-018-0262-2.

[28] Wang Z, Gu Y, Wang H, et al. FOXG1 interaction with SATB2 promotes autophagy to alleviate neuroinflammation and mechanical abnormal pain in rats with lumbar disc herniation. Ann Med. 2024; 56(1):2399967. https://doi.org/10.1080/07853890.2024.2399967.

[29] Wang Y, Tian M, Tan J, et al. Irisin ameliorates neuroinflammation and neuronal apoptosis through integrin αVβ5/AMPK signaling pathway after intracerebral hemorrhage in mice. J Neuroinflammation. 2022; 19(1):82. https://doi.org/10.1186/s12974-022-02438-6.

[30] Yun Q, Ma SF, Zhang WN, et al. FoxG1 as a potential therapeutic target for Alzheimer’s disease: modulating NLRP3 inflammasome via AMPK/mTOR autophagy pathway. Cell Mol Neurobiol. 2024; 44(1):35. https://doi.org/10.1007/s10571-024-01467-4.

[31] Hardie DG, Ross FA, Hawley SA . AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012; 13(4):251-262. https://doi.org/10.1038/nrm3311.

[32] Steinberg GR, Hardie DG . New insights into activation and function of the AMPK. Nat Rev Mol Cell Biol. 2023; 24(4):255-272. https://doi.org/10.1038/s41580-022-00547-x.

[33] Singh D. Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer’s disease. J Neuroinflammation. 2022; 19(1):206. https://doi.org/10.1186/s12974-022-02565-0.

[34] Shi FD, Yong VW . Neuroinflammation across neurological diseases. Science. 2025; 388(6753):eadx0043. https://doi.org/10.1126/science.adx0043.

[35] Lu CS, Wu CY, Wang YH, et al. The protective effects of icariin against testicular dysfunction in type 1 diabetic mice via AMPK-mediated Nrf2 activation and NF-κB p65 inhibition. Phytomedicine. 2023; 123:155217. https://doi.org/10.1016/j.phymed.2023.155217.

[36] Wu H, Zheng J, Xu S, et al. Mer regulates microglial/macrophage M1/M2 polarization and alleviates neuroinflammation following traumatic brain injury. J Neuroinflammation. 2021; 18(1):2. https://doi.org/10.1186/s12974-020-02041-7.

[37] Litwiniuk A, Juszczak GR, Stankiewicz AM, et al. The role of glial autophagy in Alzheimer’s disease. Mol Psychiatry. 2023; 28(11):4528-4539. https://doi.org/10.1038/s41380-023-02242-5.

[38] Hettige NC, Peng H, Wu H, et al. FOXG1 dose tunes cell proliferation dynamics in human forebrain progenitor cells. Stem Cell Rep. 2022; 17(3):475-488. https://doi.org/10.1016/j.stemcr.2022.01.010.

[39] Schmelzle T, Hall MN . TOR, a central controller of cell growth. Cell. 2000; 103(2):253-262. https://doi.org/10.1016/S0092-8674(00)00117-3.

[40] Xu Y, Propson NE, Du S, et al. Autophagy deficiency modulates microglial lipid homeostasis and aggravates tau pathology and spreading. Proc Natl Acad Sci U S A. 2021; 118(27):e2023418118. https://doi.org/10.1073/pnas.2023418118.

[41] Heneka MT, van der Flier WM, Jessen F, et al. Neuroinflammation in Alzheimer disease. Nat Rev Immunol. 2025; 25(5):321-352. https://doi.org/10.1038/s41577-024-01104-7.